✦ LIBER ✦

Association of Left Atrial Volume With Mortality Among ESRD Patients With Left Ventricular Hypertrophy Referred for Kidney Transplantation

✍ Scribed by Rajan K. Patel; Alan G.M. Jardine; Patrick B. Mark; Anthony F. Cunningham; Tracey Steedman; Joanna R. Powell; Emily P. McQuarrie; Kathryn K. Stevens; Henry J. Dargie; Alan G. Jardine

Book ID: 114469533
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 403 KB
Volume: 55
Category: Article
ISSN: 0272-6386
DOI: 10.1053/j.ajkd.2009.12.033

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vitamin D reduces left atrial volume in

Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease

✍ Hector Tamez; Carmine Zoccali; David Packham; Julia Wenger; Ishir Bhan; Evan App 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 482 KB

AMBIENT FINE PARTICULATE MATTER IS ASSOC

AMBIENT FINE PARTICULATE MATTER IS ASSOCIATED WITH RISK OF HOSPITALIZATION FOR ACUTE DECOMPENSATED HEART FAILURE AMONG PATIENTS WITH DEPRESSED LEFT VENTRICULAR EJECTION FRACTION

✍ Pablo Castro; Hugo Verdejo; Jeantte Vera; Luis Cifuentes; Roberto Concepción; Lu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 240 KB

Usefulness of Left Atrial Volume Index t

Usefulness of Left Atrial Volume Index to Predict Heart Failure Hospitalization and Mortality in Ambulatory Patients With Coronary Heart Disease and Comparison to Left Ventricular Ejection Fraction (from the Heart and Soul Study)

✍ Bryan Ristow; Sadia Ali; Mary A. Whooley; Nelson B. Schiller 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 359 KB

Atrial fibrillation is associated with a

Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials

✍ DanielL Dries; DerekV Exner; BernardJ Gersh; MichaelJ Domanski; MyronA Waclawiw; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Effects of losartan on cardiovascular mo

Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy. A losartan intervention for endpoint reduction (LIFE) study

✍ S.E. Kjeldsen; B. Dahlor; R.B. Devereux 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Circulating levels of asymmetric dimethy

Circulating levels of asymmetric dimethylarginine are an independent risk factor for left ventricular hypertrophy and predict cardiovascular events in pre-dialysis patients with chronic kidney disease

✍ Beili Shi; Zhaohui Ni; Wenyan Zhou; Zanzhe Yu; Leyi Gu; Shan Mou; Wei Fang; Qin 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 255 KB